Patient-reported outcomes in patients with resected, stage III BRAF V600+melanoma treated with adjuvant dabrafenib plus trametinib: COMBI-APlus study
Grob, J. J. Dutriaux, C. Del Vecchio, M. Ryll, B. Robert, C. Gogas, H. J. Menzies, A. M. Gupta, Avinash Banerjee, H. Lau, M. R.
Grob, J. J.
Dutriaux, C.
Del Vecchio, M.
Ryll, B.
Robert, C.
Gogas, H. J.
Menzies, A. M.
Gupta, Avinash
Banerjee, H.
Lau, M. R.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Grob JJ, Dutriaux C, Del Vecchio M, Ryll B, Robert C, Gogas HJ, et al. Patient-reported outcomes in patients with resected, stage III BRAF V600+melanoma treated with adjuvant dabrafenib plus trametinib: COMBI-APlus study. Annals of Oncology. 2022 Sep;33(7):S911-S2. PubMed PMID: WOS:000866211601074.